Kelly Culwell, Chief Medical Officer at Evofem Biosciences, Inc. (EVFM), sold 1,000 shares at $7.35 ($7K) on 2019-12-02, disclosed to the SEC on 2019-12-04.
Scheduled sale ($7k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EVFM | BUY | 2018-08-20 | $7K | — | Filing → |